Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
26
self-reported band not used
Founded
2017
9 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
1
Series C · May 2023 · US$ 8.1M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
SCG CELL THERAPY PTE. LTD.Entity record →
UEN201728785N
Legal entities
Show as table · SCG Cell Therapy: 1 registry entity
| SCG CELL THERAPY PTE. LTD. | UEN 201728785N |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Established and headquartered in Singapore, SCG Cell Therapy Pte Ltd (SCG) is a leading biotechnology company that combines regional advantages in Singapore, China and Germany, to cover the entire value chain from innovative drug research and discovery, manufacturing, clinical development and commercialization.
SCG specializes in the development of novel immunotherapies in infections and its associated cancers. The company targets the most common cancer-causing infections: helicobacter pylori, human papillomavirus, and hepatitis B, and develops a broad and unique pipeline of T cell therapies, antibodies, and therapeutic vaccines against infections and to prevent and cure its associated cancers.
SCG collaborates with leading scientists and researchers to bring first-in-class medical products/technologies to enhance innovation in medical product development.
Specialties
All 12 specialties
- Cell Therapy
- Bispecific Antibody
- Immunotherapy
- Scientific Research
- Therapeutic Vaccine
- Drug Product
- Medical Product
- Medical Technologies
- Cancer Prevention
- Cancer Therapy
- COVID-19 Drug
- Drug Research and Discovery
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SGSingapore, SingaporePrimary
Grid intelligence Members
Funding
Last round · 5 May 2023US$ 8.1MSeries C
Rounds1
Round typeSeries C · venture round
Amount (USD)8,100,000
Stage rank5
Investors named0
Since last round2 yr 8 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2017 to 2026 |
| Series C · 5 May 2023 | US$ 8.1M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under SCG Cell Therapy?
One Singapore entity on ACRA: SCG CELL THERAPY PTE. LTD. (UEN 201728785N), high confidence.
How many people work at SCG Cell Therapy?
26 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does SCG Cell Therapy have offices?
One address on record, Singapore only. Primary: Singapore.
Has SCG Cell Therapy raised funding?
One round. Latest 5 May 2023: Series C, US$8,100,000.
What does SCG Cell Therapy list as its specialties?
12 tags on the brand's own list, among them Cell Therapy, Bispecific Antibody and Immunotherapy.
Which companies are listed alongside SCG Cell Therapy?
Eight peer profiles on record: ESCO ASTER PTE LTD and Lion TCR.